AzaSite®

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Blepharitis

Phase 4

Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis

CompletedNCT00629980

Merck Sharp & Dohme LLCBlepharitis

Start: 2008-02-29Target: 60Updated: 2011-09-26

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

CompletedNCT00629590

Merck Sharp & Dohme LLCBlepharitis

Start: 2008-03-31Target: 20Updated: 2011-09-26

Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis

CompletedNCT00629941

Merck Sharp & Dohme LLCBlepharitis

Start: 2008-03-31Target: 25Updated: 2011-09-26

Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

CompletedNCT00656539

Merck Sharp & Dohme LLCBlepharitis

Start: 2008-04-30Target: 20Updated: 2011-09-26